DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Atgam (Equine Thymocyte Immune Globulin) - Current Clinical Trials

 
 



Atgam Related Clinical Trials

Anti-thymocyte Globulin and Cyclosporine as First-Line Therapy in Treating Patients With Severe Aplastic Anemia [Completed]

Study of Antithymocyte Globulin for Treatment of New-onset T1DM [Terminated]

Antithymocyte Globulin and Cyclosporine to Treat Myelodysplasia [Completed]

Cyclophosphamide and Anti-thymocyte Globulin Followed By Methotrexate and Cyclosporine in Preventing Chronic Graft-Versus-Host Disease in Patients With Severe Aplastic Anemia Undergoing Donor Bone Marrow Transplant [Completed]

Cytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi Anemia [Recruiting]

Antithymocyte Globulin and Cyclosporine in Treating Low Risk Patients With Myelodysplastic Syndrome [Completed]

Randomized Trial of Induction Therapies in High Immunological Risk Kidney Transplant Recipients [Completed]

Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia [Active, not recruiting]

Fludarabine Phosphate, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Peripheral Blood Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Malignancies [Active, not recruiting]

Carmustine, Etoposide, Cytarabine, Melphalan, and Antithymocyte Globulin Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Autoimmune Neurologic Disease That Did Not Respond to Previous Therapy [Recruiting]

Prednisone Withdrawal Versus Prednisone Maintenance After Kidney Transplant [Terminated]

Scleroderma Treatment With Autologous Transplant (STAT) Study [Recruiting]

Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients [Terminated]

Horse ATG in Patients With AA or Low/Int-1 Risk MDS [Recruiting]

Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Transplant [Active, not recruiting]

Cyclophosphamide, Antithymocyte Globulin, and Total-Body Irradiation in Treating Patients With Severe Aplastic Anemia Undergoing Umbilical Cord Blood Transplant [Terminated]

Allogeneic Hematopoietic Stem Cell Transplantation Using a Non-myeloablative Preparative Regimen of Total Lymphoid Irradiation and Anti-thymocyte Globulin for Older Patients With Relapsed Lymphoid Malignancies [Recruiting]

Anti-Thymocyte Globulin, Cyclosporine, and RAD in Islet Transplantation [Completed]

Anti-thymocyte Globulin and Melphalan in Treating Patients With Relapsed Multiple Myeloma [Terminated]

Phase III Randomized Study of Cyclophosphamide With or Without Antithymocyte Globulin Before Bone Marrow Transplantation in Patients With Aplastic Anemia [Completed]

Improved Induction and Maintenance Immunosuppression in Kidney Transplantation [Completed]

Zevalin Before Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma [Recruiting]

Belatacept Early Steroid Withdrawal Trial [Recruiting]

Allogenic Haematopoietic Cell Transplantation for Patients With Refractory "Triple Negative" Breast Cancer [Terminated]

Anti-thymocyte Globulins for Graft-versus-host Disease Prophylaxis [Recruiting]

Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies [Active, not recruiting]

Rituximab in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer [Active, not recruiting]

ATG-GCSF in New Onset Type 1 Diabetes [Recruiting]

Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection [Active, not recruiting]

Rabbit Antithymocyte Globulin (Thymoglobuline) With Ciclosporin for Patients With Acquired Aplastic Anaemia [Active, not recruiting]

Tandem Stem Cell Transplantation for Non-Hodgkin's Lymphoma [Recruiting]

High Dose Busulfan and Bortezomib in Treating Patients With High Risk Multiple Myeloma Undergoing Stem Cell Transplant [Terminated]

Study Comparing ABX-CBL (Monoclonal Antibody) Versus Atgam in Patients With Steroid Resistant Acute Graft Versus Host Disease [Completed]

Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer [Completed]

CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma [Recruiting]

Belatacept to Prevent Organ Rejection in Kidney Transplant Patients [Terminated]

Study of Alemtuzumab Versus Anti-thymocyte Globulin to Help Prevent Rejection in Kidney and Pancreas Transplantation [Active, not recruiting]

Phase IIA Open Label Study to Evaluate Efficacy and Safety of BL-8040 Followed by (hATG), Cyclosporine and Methyprednisolone in Adult Subjects With Aplastic Anemia or Hypoplastic Myelodysplastic Syndrome [Not yet recruiting]

Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant [Terminated]

Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Aplastic Anemia [Completed]

Fludarabine-Based Conditioning for Allogeneic Marrow Transplantation in Aplastic Anemia [Active, not recruiting]

HLA-haploidentical Hematopoietic Stem Cell Transplantation for Children and Adolescents With Acute Leukemia, Myelodysplastic Syndrome and Solid Tumors [Recruiting]

Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer [Completed]

Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant [Recruiting]

Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders [Active, not recruiting]

Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies [Recruiting]

Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic Malignancies [Recruiting]

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer [Completed]

Umbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic Cancer [Terminated]

Antithymocyte Globulin and Cyclosporine in Treating Patients With Myelodysplastic Syndrome [Completed]

A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome [Completed]

Allo Transplantation With Mylotarg, Fludarabine and Melphalan for AML, CML and MDS [Completed]

Rabbit Anti-thymocyte Globulin in the Treatment of Patients With Low to Intermediate-1 Risk Myelodysplastic Syndrome [Terminated]

Safety/Efficacy of Induction Agents With Tacrolimus, MMF, and Rapid Steroid Withdrawal in Renal Transplant Recipients [Completed]

Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic Syndromes [Completed]

Preemptive Therapy of GVHD [Recruiting]

Thymoglobulin: Presence and Affect in the Central Lymphatic Compartment [Completed]

Phase II Poor Risk Diffuse Large B-cell Lymphoma (DLBCL) of Total Lymphoid Irradiation (TLI) and Antithymocyte Globulin (ATG) Followed by Matched Allogeneic Hematopoietic Transplantation as Consolidation to Autologous Hematopoietic Cell Transplantation (AHCT) [Completed]

Early Diagnosis and Stem Cell Transplantation for Severe Immunodeficiency Diseases [Recruiting]

Ph II of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG [Active, not recruiting]

Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory or Relapsed Acute Myelogenous Leukemia [Active, not recruiting]

Antithymocyte Globulin in Treating Patients Undergoing Stem Cell Transplant for Multiple Myeloma [Completed]

SCT for Dyskeratosis Congenita or SAA [Active, not recruiting]

Treosulfan and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders [Recruiting]

EZ-2053 in the Prophylaxis of Acute Pulmonary Allograft Rejection [Completed]

Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder [Completed]

Antithymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia [Active, not recruiting]

Horse ATG/CsA in Aplastic Anemia Patients Unresponsive to or With a Suboptimal Response to Rabbit ATG/CsA Treatment [Active, not recruiting]

Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological Cancer [Completed]

Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission [Completed]

Bortezomib Before Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma [Withdrawn]

Combination Chemotherapy Followed By Donor Bone Marrow or Umbilical Cord Blood Transplant in Treating Children With Newly Diagnosed Juvenile Myelomonocytic Leukemia [Completed]

Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer [Completed]

Eltrombopag in Combination With Rabbit Anti-thymocyte Globulin/Cyclosporine A in Naive Aplastic Anemia (AA) Subjects [Recruiting]

Allogeneic Transplantation From Related Haploidentical Donors in Older Patients With Indolent Hematologic Malignancies [Completed]

Multi-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia and Other Hematologic Disorders [Completed]

Antithymocyte Globulin Compared With Supportive Care in Treating Patients With Myelodysplastic Syndrome [Active, not recruiting]

Effects of Antithymocyte Globulin in Adults With Myelodysplastic Syndrome [Recruiting]

Comparing Therapies for the Treatment of Severe Aplastic Anemia [Completed]

Cyclophosphamide, Fludarabine and Antithymocyte Globulin Conditioning in Myelodysplastic Syndrome (MDS) [Recruiting]

Phase II Pilot Study of Cyclophosphamide and Rabbit Anti-Thymocyte Globulin as Salvage Therapy in Patients With Diffuse Systemic Sclerosis [Completed]

Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation [Terminated]

Phase I Pilot Study of Total-Body Irradiation, Anti-Thymocyte Globulin and Cyclophosphamide Followed By Syngeneic or Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple Sclerosis [Completed]

Fludarabine, Busulfan, Antithymocyte Globulin, and Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma That Has Not Responded to Treatment [Completed]

Busulfan, Cyclophosphamide, and Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer [Completed]

Busulfan, Melphalan, and Antithymocyte Globulin Followed By Umbilical Cord Blood Transplant in Treating Young Patients With Refractory or Relapsed Malignant Solid Tumors [Active, not recruiting]

Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease [Active, not recruiting]

S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome [Completed]

Medical Treatment for Diamond Blackfan Anemia [Completed]

A Randomized Trial of Recombinant Humanized Anti-IL-2 Receptor Antibody (Daclizumab) Versus Antithymocyte Globulin (ATG) to Treat the Cytopenia of Myelodysplastic Syndrome (MDS) [Completed]

Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma [Recruiting]

Safety and Efficacy Study of Thymoglobulin Versus IL2 Receptor Antagonists [Active, not recruiting]

A Study To Compare Sirolimus Versus Tacrolimus In De Novo Simultaneous Pancreas- Kidney Allograft Recipients Receiving An Induction Therapy With Antithymocyte Globulin Plus Mycophenolate Mofetil Plus Corticosteroids [Active, not recruiting]

Comparison of Cy-Atg Vs Cy-Flu-Atg for the Conditioning Therapy in Allo-HCT [Completed]

The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients [Completed]

IMM 0212: Busulfan With Fludarabine and Antithymocyte Globulin as Preparative Therapy for Hematopoietic Stem Cell Transplant for the Treatment of Severe Congenital T-Cell Immunodeficiency [Completed]

TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD [Completed]

Donor Stem Cell Transplant After Busulfan, Fludarabine, Methylprednisolone, and Antithymocyte Globulin in Treating Patients With Bone Marrow Failure Syndrome [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015